A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome

被引:20
作者
Little, S
Hanks, S
King-Underwood, L
Picton, S
Cullinane, C
Rapley, E
Rahman, N
Pritchard-Jones, K
机构
[1] Inst Canc Res, Sect Paediat, Surrey, England
[2] Inst Canc Res, Sect Canc Genet, Surrey, England
[3] St James Univ Hosp, Dept Paediat Oncol, Leeds LS9 7TF, W Yorkshire, England
[4] St James Univ Hosp, Dept Pathol, Leeds LS9 7TF, W Yorkshire, England
关键词
Denys-Drash; dominant-negative; nephropathy; self-association; Wilms tumor; WT1;
D O I
10.1007/s00467-004-1649-z
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Denys-Drash syndrome (DDS) is characterized by nephropathy, genital abnormalities, and predisposition to Wilms tumor. DDS is associated with constitutional WT1 mutations, the majority being missense mutations in the zinc-finger region. A dominant-negative mode of action of the mutant DDS proteins is thought to explain the more severe genitourinary phenotype seen in DDS compared with children with complete deletion of one WT1 allele. We present a phenotypically female child who presented with bilateral Wilms tumor at 8 months of age. She was found to have an XY karyotype and diagnosed with DDS. In the constitutional DNA of this child we found a previously unreported mutation in exon 1 of WT1. This de novo mutation, delT in codon 40, is predicted to produce a termination signal in codon 90 (F40fsX90). This frameshift mutation results in a severely truncated protein, which would remove both the zinc-finger DNA-binding domain and the majority of the N-terminal regulatory domain, including regions previously shown in vitro to be necessary for inhibition of WT1 transcriptional activity. Our results provide important physiological evidence that the first 40 amino acids of WT1 are capable of functionally important interactions, presumably through their ability to self-associate with full-length WT1.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 32 条
[1]  
Baird Paul N., 1992, Human Molecular Genetics, V1, P301, DOI 10.1093/hmg/1.5.301
[2]  
Barbosa AS, 1999, HUM MUTAT, V13, P146, DOI 10.1002/(SICI)1098-1004(1999)13:2<146::AID-HUMU7>3.0.CO
[3]  
2-I
[4]   WT1 MUTATIONS ASSOCIATED WITH INCOMPLETE DENYS-DRASH SYNDROME DEFINE A DOMAIN PREDICTED TO BEHAVE IN A DOMINANT-NEGATIVE FASHION [J].
BARDEESY, N ;
ZABEL, B ;
SCHMITT, K ;
PELLETIER, J .
GENOMICS, 1994, 21 (03) :663-665
[5]   Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1 [J].
Borel, F ;
Barilla, KC ;
Hamilton, TB ;
Iskandar, M ;
Romaniuk, PJ .
BIOCHEMISTRY, 1996, 35 (37) :12070-12076
[6]   ISOLATION AND CHARACTERIZATION OF A ZINC FINGER POLYPEPTIDE GENE AT THE HUMAN CHROMOSOME-11 WILMS TUMOR LOCUS [J].
CALL, KM ;
GLASER, T ;
ITO, CY ;
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
ROSE, EA ;
KRAL, A ;
YEGER, H ;
LEWIS, WH ;
JONES, C ;
HOUSMAN, DE .
CELL, 1990, 60 (03) :509-520
[7]   MUTATIONAL SCREENING OF THE WILMS-TUMOR GENE, WT1, IN MALES WITH GENITAL ABNORMALITIES [J].
CLARKSON, PA ;
DAVIES, HR ;
WILLIAMS, DM ;
CHAUDHARY, R ;
HUGHES, IA ;
PATTERSON, MN .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (09) :767-772
[8]   DENYS-DRASH SYNDROME - RELATING A CLINICAL DISORDER TO GENETIC ALTERATIONS IN THE TUMOR-SUPPRESSOR GENE WT1 [J].
COPPES, MJ ;
HUFF, V ;
PELLETIER, J .
JOURNAL OF PEDIATRICS, 1993, 123 (05) :673-678
[9]  
DENYS P, 1967, ARCH FR PEDIATR, V24, P729
[10]   Constitutional WT1 mutations in Wilms' tumor patients [J].
Diller, L ;
Ghahremani, M ;
Morgan, J ;
Grundy, P ;
Reeves, C ;
Breslow, N ;
Green, D ;
Neuberg, D ;
Pelletier, J ;
Li, FP .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3634-3640